CTIM-30. INVESTIGATION OF THE COMBINATION OF D2C7-IT WITH AN FC-ENGINEERED ANTI-HUMANCD40 MONOCLONAL ANTIBODY (2141-V11) WHEN ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOLLOWED BY CERVICAL PERILYMPHATIC INJECTIONS (CPLIS) OF 2141-V11 COMPARED TO D2C7-IT CED MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM)
Publication
, Conference
Desjardins, A; Chandramohan, V; II, JEH; Bradbury, C; Shoaf, M; Peters, KB; Johnson, MO; Batich, K; Low, J; Khasraw, M; Friedman, AH; Grant, G ...
Published in: Neuro-Oncology
November 11, 2025
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 11, 2025
Volume
27
Issue
Supplement_5
Start / End Page
v121 / v121
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Chandramohan, V., II, J. E. H., Bradbury, C., Shoaf, M., Peters, K. B., … Bigner, D. D. (2025). CTIM-30. INVESTIGATION OF THE COMBINATION OF D2C7-IT WITH AN FC-ENGINEERED ANTI-HUMANCD40 MONOCLONAL ANTIBODY (2141-V11) WHEN ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOLLOWED BY CERVICAL PERILYMPHATIC INJECTIONS (CPLIS) OF 2141-V11 COMPARED TO D2C7-IT CED MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM). In Neuro-Oncology (Vol. 27, pp. v121–v121). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noaf201.0487
Desjardins, Annick, Vidya Chandramohan, James E Herndon II, Claire Bradbury, Madison Shoaf, Katherine B. Peters, Margaret O. Johnson, et al. “CTIM-30. INVESTIGATION OF THE COMBINATION OF D2C7-IT WITH AN FC-ENGINEERED ANTI-HUMANCD40 MONOCLONAL ANTIBODY (2141-V11) WHEN ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOLLOWED BY CERVICAL PERILYMPHATIC INJECTIONS (CPLIS) OF 2141-V11 COMPARED TO D2C7-IT CED MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM).” In Neuro-Oncology, 27:v121–v121. Oxford University Press (OUP), 2025. https://doi.org/10.1093/neuonc/noaf201.0487.
Desjardins A, Chandramohan V, II JEH, Bradbury C, Shoaf M, Peters KB, et al. CTIM-30. INVESTIGATION OF THE COMBINATION OF D2C7-IT WITH AN FC-ENGINEERED ANTI-HUMANCD40 MONOCLONAL ANTIBODY (2141-V11) WHEN ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOLLOWED BY CERVICAL PERILYMPHATIC INJECTIONS (CPLIS) OF 2141-V11 COMPARED TO D2C7-IT CED MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM). In: Neuro-Oncology. Oxford University Press (OUP); 2025. p. v121–v121.
Desjardins, Annick, et al. “CTIM-30. INVESTIGATION OF THE COMBINATION OF D2C7-IT WITH AN FC-ENGINEERED ANTI-HUMANCD40 MONOCLONAL ANTIBODY (2141-V11) WHEN ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOLLOWED BY CERVICAL PERILYMPHATIC INJECTIONS (CPLIS) OF 2141-V11 COMPARED TO D2C7-IT CED MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM).” Neuro-Oncology, vol. 27, no. Supplement_5, Oxford University Press (OUP), 2025, pp. v121–v121. Crossref, doi:10.1093/neuonc/noaf201.0487.
Desjardins A, Chandramohan V, II JEH, Bradbury C, Shoaf M, Peters KB, Johnson MO, Batich K, Low J, Khasraw M, Friedman AH, Friedman HS, Ashley DM, Grant G, Osorio J, Ravetch J, Bigner DD. CTIM-30. INVESTIGATION OF THE COMBINATION OF D2C7-IT WITH AN FC-ENGINEERED ANTI-HUMANCD40 MONOCLONAL ANTIBODY (2141-V11) WHEN ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOLLOWED BY CERVICAL PERILYMPHATIC INJECTIONS (CPLIS) OF 2141-V11 COMPARED TO D2C7-IT CED MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM). Neuro-Oncology. Oxford University Press (OUP); 2025. p. v121–v121.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 11, 2025
Volume
27
Issue
Supplement_5
Start / End Page
v121 / v121
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences